Anzeige
Mehr »
Mittwoch, 27.08.2025 - Börsentäglich über 12.000 News
Patentschutz bis in die 2040er - Biotech-Geheimtipp vor möglichem Fast-Track-Durchbruch in den USA!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41APT | ISIN: CA75103L3092 | Ticker-Symbol: 7JO0
Frankfurt
27.08.25 | 15:29
0,314 Euro
+6,44 % +0,019
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
RAKOVINA THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
RAKOVINA THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,3050,31518:54

Aktuelle News zur RAKOVINA THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiRakovina Therapeutics Inc: Rakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on Cancer Research and Apoptosis6
12.08.Rakovina Therapeutics Inc (2): Rakovina Therapeutics signs LOI for JV with NanoPalm2
12.08.Rakovina Therapeutics Inc: Rakovina Therapeutics and NanoPalm Ltd. Sign Letter of Intent to Form Joint Venture Leveraging AI-Discovered Oncology Therapies and Novel Lipid Nanoparticle Delivery Technologies394VANCOUVER, British Columbia and RIYADH, Saudi Arabia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company...
► Artikel lesen
30.07.Rakovina Therapeutics Inc (2): Rakovina grants options to buy 540,000 shares6
30.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Highlights Long-Standing Collaboration with the University of British Columbia and the Vancouver Prostate Centre331VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies...
► Artikel lesen
RAKOVINA THERAPEUTICS Aktie jetzt für 0€ handeln
29.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Stock Option Grants3
25.07.Rakovina Therapeutics Inc (2): Rakovina implements warrant exercise incentive program4
24.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Warrant Exercise Incentive Program1
23.07.Rakovina Therapeutics Inc (2): Rakovina's KT-5000AI generates ATR inhibitor candidates1
23.07.Rakovina Therapeutics Inc: Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening383VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V:?RKV) (FSE:?7JO0), a biopharmaceutical company advancing next-generation...
► Artikel lesen
15.07.Rakovina Therapeutics Inc (2): Rakovina Therapeutics receives DTC eligibility7
15.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Granted DTC Eligibility to Expand U.S. Investor Access169VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation...
► Artikel lesen
13.07.Diese Aktie zeigt die wissenschaftliche Schlagkraft hinter ihrer KI-gesteuerten Krebsforschung
11.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Congratulates Partner - Variational AI for Winning LifeSciencesBC's 2025 Emerging Biotech Company of the Year Award30
10.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development4
01.07.Rakovina Therapeutics Inc (2): Rakovina to seek TSX-V OK to amend warrants, debentures48
01.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Intention to Amend Debentures and Warrants29
30.06.Rakovina Therapeutics Inc (2): Rakovina plans kt-3283 development partnerships for Q321
30.06.Rakovina Therapeutics Inc: Rakovina Therapeutics Highlights Strong H1 Progress and Unveils Strategic Priorities for H2 2025397VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation...
► Artikel lesen
26.06.Rakovina Therapeutics Inc (2): Rakovina shareholders elect five directors at AGM6
Weiter >>
61 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1